PYRIDOXOL
Myocardial Infarction
Hamilton Health Sciences CorporationSmall moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 61/ 100
- Competitive Position
- 89/ 100
Competitive context
10 Active assets in the Myocardial Infarction cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Aspirin Shanghai CureGene Pharmaceutical Co., Ltd. | Phase 4 | A |
CLOPIDOGREL Shanghai CureGene Pharmaceutical Co., Ltd. | Phase 4 | A |
Ticagrelor Assistance Publique - Hôpitaux de Paris | Phase 4 | BBB |
Folic Acid Hamilton Health Sciences Corporation | Phase 4 | BBB |
Dabigatran St. Antonius Hospital | Phase 4 | BB |
View all 37 →
Same molecule, other indications
PYRIDOXOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →